Author

Sevinç Jakab

Observed names: Sevinc Jakab, Sevinç Gücüm

Institutions: University of California, San Francisco, University of California San Francisco Medical Center

Observed institutions: German Cancer Research Center, University of California, San Francisco, Heidelberg University, University of California San Francisco Medical Center, DKFZ-ZMBH Alliance, Heidelberg Institute for Stem Cell Technology and Experimental Medicine

ORCID: 0000-0002-4604-6114

Observed ORCID: 0000-0002-4604-6114

OpenAlex ID: A5047769670

Lung endothelium exploits susceptible tumor cell states to instruct metastatic latency

2024 · Moritz Jakab, Ki Hong Lee, et al. · Nature Cancer · 39

Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling

2025 · Roberto Würth, Elisa Donato, et al. · Nature Cancer · 37

A rapid and simple procedure for the isolation and cultivation of fibroblast-like cells from medaka and zebrafish embryos and fin clip biopsies

2021 · Lars Beedgen, Andreas Hüllen, et al. · Laboratory Animals · 3

Establishing an auxin-inducible GFP nanobody-based acute protein knockdown system to mimic hypomorphic mutations during early medaka embryogenesis

2025 · Kaisa Pakari, Sevinç Jakab, et al. · Biology Open · 2

Severity of Tauopathy and Beta-amyloidosis in Logopenic Variant Primary Progressive Aphasia in Individuals With or Without a History of Developmental Dyslexia (N1.001)

2026 · Salvatore Spina, Zachary Miller, et al. · Neurology

Severity of tauopathy differs between logopenic variant primary progressive aphasia individuals with or without a history of learning differences

2026 · Salvatore Spina, Zachary A. Miller, et al. · medRxiv

Works count: 6

Citation count: 81

H-index: 3

I10-index: 2